Zogenix, Inc. (ZGNX) News Headlines

▮ More

Date

Headline

10/15/2020 5:52:16 PM After Market Hours: Flexible Solutions, Zogenix, PQ Group Gain; Del Taco, Marten Transport Slips

9/23/2020 11:28:33 PM Zogenix Prices Offering Of $200 Mln Aggregate Principal Amount Of 2.75% Convertible Senior Notes Due 2027

9/23/2020 9:51:50 AM Stock Alert: Zogenix Tumbles 15%; Proposes $200 Mln Note Offering

9/21/2020 8:18:36 AM Zogenix Appoints Caroline Loewy, Mary Stutts And Denelle Waynick To Newly Created Seats On Board

6/26/2020 8:30:43 AM Stock Alert: Zogenix Shares Up 17% In Early Trade On FDA Approval For Fintepla

6/25/2020 11:43:00 PM FDA Approves Zogenix's Fintepla To Treat Seizures Associated With Dravet Syndrome

6/25/2020 11:31:36 PM FDA Oks Zogenix's FINTEPLA To Treat Seizures Associated With Dravet Syndrome; Commercial Launch Planned For July 2020

6/12/2020 8:11:23 AM Zogenix Unveils New Resources For Dravet Syndrome Siblings

5/26/2020 1:38:19 AM Biotech Stocks Facing FDA Decision In June 2020

4/20/2020 8:13:11 AM Zogenix Appoints Shawnte Mitchell To Role Of EVP, General Counsel And Secretary

2/27/2020 11:37:07 PM FDA Nod For BHVN's Drug, IBIO On Watch, SGMO Soars On Biogen Deal

2/27/2020 10:47:57 AM Stock Alert: Zogenix Loses 14%

2/7/2020 9:54:08 AM Stock Alert: Zogenix (ZGNX) Plunges 29%

12/17/2019 7:41:25 PM Zogenix : FINTEPLA Shows Dose-dependent Reduction In Convulsive Seizure Frequency In Dravet Syndrome Patients

11/26/2019 1:45:46 AM CCXI Is Red Hot, ZGNX On Watch, FDA Snubs ADMP

11/25/2019 8:05:23 AM Zogenix Reports FDA Acceptance For Filing Of NDA, Priority Review For FINTEPLA

10/7/2019 8:05:54 AM Zogenix Subsidiary, Modis Therapeutics, Presents Positive Top-line Results From Pivotal Phase 2 RETRO Study

9/26/2019 7:16:08 AM Zogenix Resubmits New Drug Application For FINTEPLA

9/9/2019 8:13:20 AM Zogenix Completes Acquisition Of Modis Therapeutics

8/26/2019 7:09:51 AM Zogenix To Acquire Modis Therapeutics